Literature DB >> 15252215

The DAS28 in rheumatoid arthritis and fibromyalgia patients.

B F Leeb1, I Andel, J Sautner, T Nothnagl, B Rintelen.   

Abstract

OBJECTIVE: To compare the DAS28 (Disease Activity Score including a 28-joint count) values of rheumatoid arthritis (RA) and fibromyalgia (FM) patients, and to establish whether high pain levels and impaired mood influence DAS28 values.
METHODS: DAS28 values were calculated in 62 consecutive patients with RA and in 26 patients suffering from FM. Values for DAS28 scores as well as for the single items of the patient cohorts were compared using Student's t-tests. To evaluate the item weighting and internal consistency of the total score factor analysis was performed and Cronbach's alpha calculated.
RESULTS: RA patients showed a mean DAS28 score of 4.23 (+/-1.2; range 0.77-7.46) and in FM patients the mean DAS28 came to 4.04 (+/-1.13; range 1.19-6.28). DAS28 values of RA and FM patients were not significantly different statistically. Comparing the single components of the score, however, highly significant differences (P<0.0005) occurred between RA and FM patients. Cronbach's alpha for the DAS28 in RA patients amounted to 0.7329, indicating high internal consistency, whereas in FM patients it was 0.4832.
CONCLUSION: The DAS28, as expected, proved to be inappropriate to express disease activity in FM patients. DAS28 values for expressing disease activity in RA patients may be flawed by coexisting FM and should therefore be regarded with caution as high pain levels more than impaired mood may lead to higher total scores.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252215     DOI: 10.1093/rheumatology/keh322

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  35 in total

Review 1.  My treatment approach to rheumatoid arthritis.

Authors:  John M Davis; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

2.  Analysis of the correlation between disease activity score 28 and its ultrasonographic equivalent in rheumatoid arthritis patients.

Authors:  Roxana Coras; Gustavo Añez Sturchio; Mireia Barceló Bru; Agustí Sellas Fernandez; Sandra Farietta; Salvador Campos Badia; Basilio Rodríguez Diez; Juan José de Agustín de Oro
Journal:  Eur J Rheumatol       Date:  2020-07-21

3.  Great expectations of modern RA treatment.

Authors:  S Irvine; H C Capell
Journal:  Ann Rheum Dis       Date:  2005-09       Impact factor: 19.103

4.  The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Piercarlo Sarzi-Puttini
Journal:  Rheumatol Int       Date:  2018-06-28       Impact factor: 2.631

5.  [Austrian expert opinion on the standard for expert assessment of course of illness in patients with chronic polyarthritis (rheumatoid arthritis)].

Authors:  Klaus P Machold; Hans Peter Brezinsek; Burkhard F Leeb; Stephan Pflugbeil; Franz Rainer; Franz Singer; Martin Skoumal; Tanja A Stamm; Manfred Herold
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

6.  The overestimation of disease activity in patients with rheumatoid arthritis and concomitant fibromyalgia.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

7.  The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort.

Authors:  Josefina Durán; Bernard Combe; Jingbo Niu; Nathalie Rincheval; Cécile Gaujoux-Viala; David T Felson
Journal:  Rheumatology (Oxford)       Date:  2015-07-14       Impact factor: 7.580

8.  [Recommendations of the Austrian Society of Rheumatology/Austrian Radiology-Rheumatology Initiative for Musculoskeletal Ultrasound for the application of ultrasound in rheumatology].

Authors:  Christina Duftner; Christian Dejaco; Franz Kainberger; Klaus Machold; Peter Mandl; Thomas Nothnagl; Tobias DeZordo; Rusmir Husic; Claudia Schüller-Weidekamm; Michael Schirmer
Journal:  Wien Klin Wochenschr       Date:  2014-10-02       Impact factor: 1.704

9.  Patients with active rheumatoid arthritis but only few tender and swollen joints: a subgroup with impaired short term outcome.

Authors:  C Fiehn; S Kessler; W Drexler; H M Lorenz
Journal:  Rheumatol Int       Date:  2008-11-08       Impact factor: 2.631

10.  Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity.

Authors:  Kimme L Hyrich; Chris Deighton; Kath D Watson; Deborah P M Symmons; Mark Lunt
Journal:  Rheumatology (Oxford)       Date:  2009-08-25       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.